Acasti Pharma Inc — Perfil da empresa, notícias e dados financeiros
Acasti Pharma develops innovative therapies for rare and orphan diseases, focusing on enhancing patient care with its robust pipeline.
Acasti Pharma Inc
Sobre
Acasti Pharma (NASDAQ:ACST) is a biopharmaceutical company dedicated to improving the treatment of rare and orphan diseases. Traded under the symbol ACST on NASDAQ, the company focuses on developing and commercializing innovative pharmaceutical therapies. Acasti leverages its proprietary technologies to tackle medical challenges, with a robust pipeline of products in various stages of development. The company's objectives revolve around advancing its clinical programs, securing regulatory approvals, and exploring strategic partnerships. Acasti aims to make a significant impact in the realm of healthcare by providing effective solutions that address unmet medical needs and enhance the lives of patients worldwide.
Resumo
Operações
Produtos e/ou serviços de Acasti Pharma Inc
- The lead project focuses on creating a prescription-grade omega-3 phospholipid therapy designed to treat severe hypertriglyceridemia with better absorption compared to existing omega-3 therapies.
- Efforts are underway to develop a lipid modulation therapy focusing on controlling lipid metabolism disorders, targeting cardiovascular health improvements.
- Research aims to pioneer a medical treatment that harnesses omega-3 based molecules, designed to improve the bioavailability of heart-health supplements.
- Development is centered on novel drug compounds aimed to offer unique profiles for chronic cardiovascular conditions.
- R&D initiatives are directed towards creating a platform for proprietary formulation technologies to enhance efficacy and patient compliance.
- Work includes strategic collaborations and partnerships to expand and accelerate the development pipeline for novel cardiovascular therapies.
equipe executiva do Acasti Pharma Inc
- Mr. Prashant KohliCEO & Director
- Mr. Amresh Kumar Ph.D.VP of Program Management
- Ms. Carrie D'AndreaVP of Clinical Operations
- Dr. R. Loch MacDonald M.D., Ph.D.Member of Scientific Advisory Board & Chief Medical Officer
GARANTA JÁ SEU GRAFA EDGE
Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas